Stroke - McMaster Experts

publication venue for

Proteome-wide Mendelian Randomization Screen Identifies Circulating Protein Mediators Of Early-onset Ischemic Stroke 2023
Sex-stratified Transethnic GWAS Meta-analysis Identifies Novel Candidates For Early Onset Ischemic Stroke 2023
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials 2022
Abstract 154: Sex-specific Genome Wide Association Study Of Early-onset Ischemic Stroke 2022
Abstract TP186: Heterogeneity Of Endovascular Treatment Effect: A Comparison Of Subgroup Identification Methods In Acute Stroke Trials 2022
Effects Of Oral Factor Xa Inhibitors On Ischemic Stroke In Patients Without Atrial Fibrillation: Systematic Review Of Randomized Clinical Trials 2022
Abstract MP5: Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis 2021
Abstract P3: Andexanet Alfa for Acute Bleeding During Treatment With Edoxaban 2021
Abstract P411: Prevalence, Characteristics and Outcomes of Undetermined Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis 2021
Genome-wide Association Study of Early-Onset Ischemic Stroke Identifies Novel Locus on Chromosome 12 Near BCL7A/MLXIP 2020
Diffusion Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage: A Pooled Analysis of Individual Patient Data From MISTIE-III, ATACH-II, I-DEF, and ERICH 2020
Recurrent Stroke in Middle-Aged Lacunar Stroke Survivors: Understanding Risk Factors and Vulnerability in an Important Target Population 2020
Statin Treatment and Accrual of Covert Cerebral Ischemia on Neuroimaging: A Systematic Review and Meta-analysis of Randomized Trials 2020
Statin Treatment and Prevalent Cerebral Microbleeds: A Systematic Review and Meta-analysis of Randomized Trials 2020
Thrombolysis for AIS in the Unwitnessed or Extended Therapeutic Time Window: A Systematic Review and Meta-Analysis 2020
Cerebral Microbleeds and the Effect of Anticoagulation on Outcomes in 3699 Patients With Embolic Strokes of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial. 2019
Effect of Oral Factor Xa Inhibitors on the Risk of Subdural Hematoma: COMPASS trial Results and Systematic Review 2019
Cerebral Microbleeds and Cognition in Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes Trial 2018
Change in Antiplatelet Therapy in Prevention of Secondary Stroke (CAPS2) Study 2018
Characterization of Patients With Embolic Strokes of Uncertain Source in the Navigate-ESUS Trial 2018
First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study 2018
Mortality After Pediatric Arterial Ischemic Stroke: Results From the International Paediatric Stroke Study 2018
NAVIGATE ESUS Trial: Geographical Variations in Ineligibility Rates and Causes 2017
Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers. 2016
Association between Paroxysmal Supraventricular Tachycardia and Ischemic Stroke in Patients Without Atrial Fibrillation. 2016
Cerebral Microbleeds are Associated With Incident Dementia: The Framingham Heart Study 2016
Cerebral Microbleeds in Transient Ischemic Attack and Minor Cerebrovascular Events 2016
Cognitive Profile of Non-demented Cerebral Amlyoid Angiopathy Patients 2016
Cortical Superficial Siderosis in Community-dwelling Subjects: The Framingham Heart and Rotterdam Studies 2016
Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From REVERSE AD. 2016
Frequency of Intracranial Arterial Imaging and its Yield in Consecutive Patients with Non-lacunar Cryptogenic Ischemic Stroke: ESUS Global Registry 2016
Influence of Aversion to Uncertainty in STROKE Care. 2016
Patterns of Stroke Transfers and Predictors for Thrombectomy Post-MR CLEAN: a Single Center Experience 2016
Physicians' Preferences in the Management of Silent Stroke: Results From a Worldwide Survey. 2016
Prediction of Recurrent Stroke in Lacunar Stroke Patients: Performance of the Small Vessel Disease (SVD) Score in the SPS3 Trial 2016
Arterial Stiffness in Older Adults With and Without Stroke 2015
Association Between Serum Leptin Levels and Stroke: Results from Framingham Heart Study 2015
Cerebral Microbleeds and Cognition: The Framingham Heart Study 2015
Cerebral Microbleeds and Physical performance: The Framingham Heart Study 2015
Cerebral Microbleeds in 1278 Lacunar Stroke Patients: The Secondary Prevention of Small Subcortical Strokes (SPS3) Trial 2015
Effect of Blood Pressure and Collateral Flow on Infarct Growth Rate 2015
Frequency Aad Features of Patients With Embolic Strokes of Underdetermined Source (esus): Esus Global Registry 2015
High Serum Insulin-Like Growth Factor 1 is Associated with Lower Risk of Ischemic Stroke: The Framingham Heart Study 2015
Incidence and Etiology of Punctate Infarcts in Ischemic Stroke Patients 2015
Sensitivity and Reliability of MRI SWI Compared With GRE Sequences for Detecting Microbleeds in a Community Population 2015
A Regional Approach to Creating a Stroke Passport 2014
A Telehealth Intervention to Promote Healthy Lifestyles After Stroke: the Stroke COACH Protocol 2014
Abnormal Left Ventricular Geometry in Lacunar Stroke: the SPS3 Trial 2014
Achieving Regular Multi-Centre Performance Reporting Within A Stroke Region 2014
Blood Pressure and Brain Atrophy in a Canadian Community-based Study 2014
Characterizing Endothelial Function in Individuals Living in the Community Following Stroke 2014
Development of a Stroke Staff Orientation and Competency Framework using LEAN methodology 2014
Frequency and Features of Patients with Embolic Stroke of Undetermined Source(ESUS) 2014
Global Survey of the Diagnostic Evaluation and Management of Cryptogenic Ischemic Stroke 2014
Integrating Motor Learning and Virtual Reality Into Practice: a Knowledge Translation Challenge 2014
Re-hospitalization in the First Year After Inpatient Stroke Rehabilitation: Trends and Perspectives 2014
Systematic Review: Interventions for Covert Stroke 2014
What About the Other 12 Hours? Development and Pilot Testing of a Novel Program to Increase Walking-Related Practice During Stroke Rehabilitation 2014
Anterior Cerebral Artery Diameter Predicts Anterior Cerebral Artery Territorial Stroke 2014
Diagnostic Value of Lobar Hemorrhages for Cerebral Amyloid Angiopathy in Hospital and Community-Based Individuals: A Pathological Correlation Study 2014
Inflammatory Biomarkers and Incident Stroke in the Framingham Offspring Study 2014
Radiographic Markers of Small Vessel Disease in Young Stroke Patients 2014
'Spot Sign' Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (SPOTLIGHT): Rationale and Design of a Canadian Image-Guided Randomized Controlled Trial of Recombinant Factor VIIa 2013
A Geoinformatic Analysis of the Impact of Telestroke on Access to Stroke Thrombolysis in Ontario 2013
Apixaban Versus Aspirin in Atrial Fibrillation Patients >= 75 Years Old: an Analysis From the AVERROES Trial 2013
Assessment of Delays in Presentation to Stroke Prevention Clinics After TIA or Minor Stroke: a Preliminary Analysis 2013
Cerebral Vasospasm and Delayed Cerebral Ischemia in Subarachnoid Hemorrhage: a Contemporary Case Series 2013
Development and Evaluation of a Health Economics Measure for Quality of Life in Aphasia Post-Stroke 2013
Emergency Department Transient Ischemic Attack Clinical Pathway: Improving Quality of Care and Patient Safety Using Etiology-based Triage 2013
Frequent Atrial Premature Beats Predict Occult Paroxysmal Atrial Fibrillation in Patients with Cryptogenic Stroke: Results From the Embrace Multicentre Trial 2013
Implementation of the Revised Provincial Acute Stroke Redirect Protocol in Urban and Rural Settings 2013
Incidental Small Acute Brain Infarcts Are Rare in Neurologically Asymptomatic Community-Dwelling Older Adults 2013
Is the FIM (R) a Sufficient Measure of Communication Change in Stroke? 2013
National Survey of Neurologists for TIA Risk Stratification Consensus and Appropriate Treatment for a Given Level of Risk 2013
One-Year Experience of a Carotid Intervention Quality Assurance Initiative using a Carotid Revascularization Performance Feedback Letter 2013
Outcomes in People Following Stroke Attending an Adapted Cardiac Rehabilitation Exercise Program: Does Time from Stroke Make a Difference? 2013
Predictors of Stroke Recurrence in Patients with Recent Lacunar Stroke: Secondary Prevention of Small Subcortical Strokes (SPS3) Trial 2013
Results from the Ontario Stroke Registry's Audit of Secondary Stroke Prevention Clinics 2013
Supporting Therapists to Integrate Virtual Reality Systems Within Clinical Practice: a Knowledge Translation Study 2013
The Effect of Interventions on Balance Self-Efficacy in the Stroke Population: a Systematic Review and Meta-analysis 2013
The Predictive Ability of the CTA Spot for Hematoma Enlargement is Dependent on Time Since ICH Onset: a Systematic Review and Patient-Level Meta-Analysis 2013
The influence of a single bout of aerobic exercise on speed of processing and muscle activity in stroke 2013
Vitamin K Antagonists versus Antiplatelet Monotherapy and Risk of Subdural Hematoma: Meta-analysis of Randomized Clinical Trials 2013
Baseline Characteristics And Functional Outcomes Of Pontine And Non-pontine Infarcts: On Behalf Of The Secondary Prevention Of Small Subcortical Strokes (SPS3) Investigators 2013
Effect Of Addition Of Clopidogrel To Aspirin On Stroke Incidence: Meta-analysis Of Randomized Trials 2013
Effect of Statin Treatment Before and After Hospitalization on Mortality Following Acute Ischemic Stroke: Importance of Confounding by Stroke Severity and Palliative Care 2013
Efficacy Of Antiplatelet Therapy For Secondary Stroke Prevention Following Lacunar Stroke: A Meta-analysis And Pooled Analysis Of Randomized Controlled Trials 2013
Framingham Stroke Risk Score and Stroke Mortality Among Canadian Adults 2013
Granuloctye-Colony Stimulating Factor in Ischemic Stroke Trial (GIST): A Pilot Study 2013
No Independent Association Between Extended-Release Niacin (ERN) Therapy and Ischemic Stroke in Patients with Established Cardiovascular Disease: A Detailed Analysis from the AIM HIGH Trial 2013
Stroke-Related Specific Mortality and Influencing Factors in Patients with Atrial Fibrillation in the RE-LY Trial 2013
The Canadian TIA Rule - A Decision Rule to Predict the Risk Of Stroke Within Seven Days In The Emergency Department 2013
The Neurovision Pilot Study: Noncardiac Surgery Carries A Significant Risk Of Acute Covert Stroke 2013
"Spot sign" selection of intracerebral hemorrhage to guide hemostatic therapy (spotlight): rationale and design of a Canadian image-guided randomized controlled trial of factor vIIa 2012
30-Day cardiac event monitor belt for recording paroxysmal atrial fibrillation after a cerebral ischemic event (embrace): a Canadian multicentre randomized trial 2012
A pilot study of the evaluation of the family/informal caregiver stroke self managment project (FICSS): impact on caregiver psychosocial, emotional and health needs 2012
Description of a carotid intervention quality assurance initiative through development of a carotid revascularization performance feedback letter 2012
FIT for FUNCTION community stroke wellness program: a pilot randomized controlled trial 2012
Gait, groceries, and golfing: using the patient specific function scale to identify and rate walking-related goals following stroke 2012
Guanosine protects against reperfusion injury in rat brains after ischemic stroke 2012
Hands-on or hands-off? Assessing the impact of manual guidance on learning a challenging walking task after stroke: a pilot study protocol 2012
Identification of potential candidates for carotid revascularization in a multicentre, point-of-care, quality assurance project evaluating patient access to carotid ultrasound in southern Ontario 2012
Is AF the underlying cause of TIA?: Factors that increase the probability of atrial fibrillation in patients with transient ischemic attack 2012
Maximizing clinicians' knowledge of stroke rehabilitation best practices: effectiveness of an e-learning intervention 2012
Physical fitness after stroke: correlates with cognition and executive function 2012
Predictors of mild cognitive impairment in persons attending a stroke prevention clinic 2012
Prevalence of carotid artery disease and associated vascular risk factors in a multicentre, point-of-care, quality assurance project evaluating patient access to carotid ultrasound in southern Ontario 2012
Satisfaction with palliative care after stroke: a prospective cohort study 2012
The association between patient characteristics, stroke severity, disability, length of stay in hospital and mortality in smokers and non-smokers with cerebrovascular disease 2012
The effects of an aerobic and resistance exercise training program on cognition following stroke 2012
Vitamin D status in the setting of acute stroke 2012
Which of your patients are ready to quit smoking? 2012
Prevalence and Characterization of Cerebral Microbleeds in Lacunar Stroke Patients: Observations from the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial 2012
"Spot Sign" selection of intracerebral hemorrhage to guide hemostatic therapy (spotlight): design of a Canadian image-guided randomized controlled trial of recombinant factor viia 2011
30-Day cardiac event monitor belt for recording paroxysmal atrial fibrillation after a cerebral ischemic event (embrace): a Canadian multicentre randomized trial 2011
Canadian cardiovascular society antiplatelet guidelines 2011
Cardiovascular risk factor correlates with arterial stiffness in community-dwelling individuals with stroke 2011
Computed tomography identifies patients at high risk for stroke after transient ischemic attack: a prospective, multi-centre cohort study 2011
Content evaluation of the family informal caregiver education and support program 2011
Detection of cognitive impairment in a stroke prevention clinic using the moca: rationale for prospective validation of a mini-MoCA 2011
Door to needle under thirty minutes: a nursing based thrombolysis team can make a difference 2011
Elemental distribution in intracerebral hemorrhagic stroke and its correlation with susceptibility change in MRI 2011
Fit for function: a community wellness program for persons with stroke 2011
Identification of delays in carotid intervention from a prospective series of consecutive patients undergoing carotid ultrasound 2011
Indirect stroke costs: the economic burden of ischemic stroke (burst) in the first 6 months post stroke 2011
Individuals with stroke secondary to GCA have a high frequency of superficial temporal, internal carotid and vertebral artery stenoses on CTA and MRA 2011
Integrating aerobic training into clinical practice within a sub-acute stroke rehabilitation program: a feasibility study 2011
Is intravenous thrombolytic therapy safe in acute stroke despite a recent ischemic event? 2011
Life after stroke, making it happen: community stroke rehabilitation teams improve quality of life and ability to stay at home for stroke survivors 2011
Optimal challenge point: task training compared to standard physiotherapy training for upper limb recovery after a stroke 2011
Palliative care in acute stroke and its effects on symptom management and family satisfaction: a systematic review 2011
Prevalence of orthostatic hypotension after stroke 2011
Rationale, design and preliminary findings of the prospective urban-rural epidemiologic mind (Pure-Mind) MRI Study 2011
Smokers have TIA or stroke at a younger age than non-smokers 2011
Smoking cessation in cerebrovascular disease: a systematic review on the effects of smoking cessation on stroke recurrence, morbidity and mortality in patients with cerebrovascular disease 2011
Statin discontinuation is associated with poor outcomes following intracerebral hemorrhage 2011
The addition of CT imaging to the ABCD2 score improves the ability to identify individuals at medium and high risk of stroke after TIA 2011
Transient isolated dysphasia is associated with a high rate of potential cardiac sources for embolism 2011
AVERROES: Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Strokes 2011
Are Stroke Suvivors Getting the Rehabilitation Services they Need? 2011
Computer Tomography Identifies Patients at High Risk for Stroke After Transient Ischemic Attack: a Prospective, Multi-Centre Cohort Study 2011
Effect of Apixaban on Covert Stroke and Cognitive Function: AVERROES MRI-Brain Assessment Trial 2011
Neurologic Safety Event Rates in the SENTIS Control Population 2011
Palliative Care in Acute Stroke and its Effects on Symptom Management and Family Satisfaction: A Systematic Review 2011
Statin Discontinuation is Associated with Poor Outcomes Following Intracerebral Hemorrhage 2011
The Addition of CT Imaging to the ABCD2 Score Improves the Ability to Identify Individuals at Medium and High Risk of Stroke 2011
The PLAN Score: A Simple Prediction Rule for Death and Severe Disability Following Acute Ischemic Stroke 2011
The Short-term Functional Outcome in Patients with Lacunar Stroke. Observations from the SPS3 Study 2011
Transient Isolated Dysphasia is Associated With a High Rate of Potential Cardiac Sources for Embolism 2011
(Almost) 10 years of secondary stroke prevention clinic services in Hamilton, Ontario 2010
30-day cardiac Event Monitor Belt for Recording paroxysmal Atrial fibrillation after a Cerebral ischemic Event (EMBRACE): randomized controlled trial 2010
Ability to achieve minimal exercise training recommendations following stroke (a pilot study) 2010
Adapting cardiac rehabilitation for individuals with stroke 2010
An academic half-day in stroke prevention developed for the family medicine residency training program at the University of Toronto 2010
CTA source images are flow weighted 2010
Costs of an ischemic stroke patient in Canada: 6 month costs 2010
Detecting change after exercise post-stroke - relationship between perceived versus actual change in balance and walking 2010
Detecting cognitive impairment in cerebrovascular disease: a sub-analysis of the tailored interventions to improve management of hypertension after stroke of TIA pilot study (TIMS) 2010
Development of the Self-management and Task-oriented Approach to Rehabilitation Training (START) at home: a knowledge translation study 2010
Estimation of acute stroke patients' weight for tPA treatment can lead to dose overcalculation and increased risk of hemorrhagic transformation 2010
Improving cardiovascular health at the population level: a 39 community cluster-randomized trial of the Cardiovascular Health Awareness Program (C-CHAP) 2010
Isolated dysarthria is a strong predictor of early recurrent stroke 2010
Physiological outcomes in stroke patients attending a cardiac rehabilitation program: does time from stroke make a difference? 2010
QUIT - a pilot trial of standardized counselling and cost free pharmacotherapy for smoking cessation in secondary stroke prevention 2010
Role of activity in the reduction of depressive symptoms post stroke 2010
Stroke mortaltiy: derivation and validation of a clinical risk score 2010
Stroke units improve outcomes by following stroke best practices 2010
Acute Stroke Patients Treated With IV tPA Based on "Time Last Seen Normal" Have Lower Rates of Hemorrhagic Transformation Than Patients With a Witnessed Symptom Onset 2010
Impact of Disability Status on Ischemic Stroke Costs 2010
Is There a Relationship Between Metabolic Syndrome and Lacunar Stroke? For the SPS3 Investigators 2010
Premature Risk of Stroke in Recent Immigrants (PRESARIO): Population-based Matched Cohort Study 2010
Stratified, Urgent Care for TIA Results in Low Stroke Rates 2010
Videoconference Delivery of a Stroke Self-Management Program: A Mixed Methods Waiting List Randomized Controlled Trial 2010
A Prospective Multicenter Cohort Study On Heparin-induced Thrombocytopenia In Acute Ischemic Stroke Patients 2009
Determining the Need for Inpatient Rehabilitation Services Post Stroke in Southwestern Ontario: Inter-rater Reliability of a Screening Tool 2009
Effect Of Telmisartan On Functional Outcome, Recurrence And Blood Pressure In Patients With Acute Ischaemic Stroke: A PRoFESS Substudy 2009
Effect of Telmisartan on Cognitive Decline following stroke: PRoFESS Cognitive Sub-study. 2009
Etiology and Clinical Outcome of Stroke in Patients under 45 years. 2009
Homocysteine Lowering Therapy And Stroke Risk, Severity And Disability: Results From The HOPE-2 Trial 2009
A 30-day cardiac event monitor belt for recording paroxysmal atrial fibrillation after a cerebral ischemic event: The EMBRACE pilot study 2008
Acute stroke CT perfusion imaging profiles predict outcomes of early intravenous thrombolytic therapy 2008
Caregiver utilization after an ischemic stroke: Preliminary results from the BURST study 2008
Comparing variables associated with 7-day, 30-day and 1-year stroke mortality indicators 2008
Disability and health preference after an ischemic stroke: Preliminary results from the BURST study 2008
Organized care and impact on stroke outcome 2008
Single vs. multiple lacunar infarcts. Are they caused by different diseases? The SPS3 study 2008
The role of CT perfusion in quantifying extent of small vessel ischemia. 2008
Association between time-to-presentation and clinical outcome in patients with subarachnoid hemorrhage 2007
CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage 2007
Endogenous thrombospondins 1 and 2 are necessary for synaptic plasticity and spontaneous functional recovery after stroke 2007
Gastrointestinal bleeding after acute ischemic stroke: Incidence, risk factors, and clinical outcomes 2007
Hemorrhagic transformation of arterial ischemic stroke in children 2007
Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter following acute ischemic stroke: A systematic review 2007
Preadmission medications are associated with improved outcomes following ischemic stroke: A cohort from the registry of the Canadian stroke network 2007
Regional differences in stroke subtypes in clinical trials of secondary prevention: The profess experience 2007
Secondary stroke prevention in the emergency department: The experience of a regional stroke center in the implementation of an evidence-based transient ischemic attack protocol in the emergency department 2007
Stroke mortality: What do the 7-day, 30-day, and 1-year indicators measure? 2007
Stroke: High volumes, low in-hospital mortality 2007
Thrombolysis in children with arterial ischemic stroke: Initial results from the international pediatric stroke study 2007
3-dimensional high-resolution magnetic resonance direct thrombus imaging: Detection of carotid AHA type VIb/c plaque 2006
Immediate impact of a citywide prehospital redirect protocol for increasing access to thrombolytic therapy for acute stroke 2006
Influence of preadmission antithrombotic therapy on stroke severity in patients with atrial fibrillation 2006
Relative importance of individual vascular risk factors for competing risk of ischemic stroke and myocardial infarction 2006
Paraventricular white matter tract damage is a critical substrate of hemispatial neglect 2005
Predictors of response to low-molecular-weight heparin following ischemic stroke in patients with atrial fibrillation: A subgroup analysis of HAEST 2005
Stroke survivors' behavioral and psychological symptoms of depression affect informal caregiver mental health 2005
The stroke self-management program is associated with increased participation in community-dwelling stroke survivors 2005
Thyroid replacement therapy is a risk factor for atrial fibrillation in stroke patients 2005
Clasmatodendrosis likely represents astrocytic response to chronic ischemia 2004
Do white matter hyperintensities on MRI in mixed Alzheimer's and cerebrovascular disease put the cholinergic system in double jeopardy? 2004
Integration across the stroke care continuum 2004
Long term outcome of angiographic abnormalities in children with cranio-cervical arterial dissection 2004
Predictors of recurrent thrombo-embolic events in 1745 infants and children with cerebral Sinovenous thrombosis: Results from the Canadian registry 2004
Upper extremity muscle strength is a vital factor in the performance of daily tasks and quality of life in individuals with stroke 2004
A study of platelet response to aspirin in children with arterial ischemic stroke utilizing the PFA 100 Analyzer 2004
Plavix (clopidogrel) in pediatric stroke: Monitoring of side effects and parent education strategies. 2004
Protein Z in ischemic stroke and its etiologic subtypes 2003
Secondary prevention of small subcortical strokes (SPS3) pilot trial: Final results 2003
Inherited thrombophilia in ischemic stroke and its etiological subtypes 2002
Chickenpox and Stroke in Childhood 2001
Perfusion Mapping Using Computed Tomography Allows Accurate Prediction of Cerebral Infarction in Experimental Brain Ischemia 2001
Prevalence of intracranial large artery stenosis in china: A population-based study 2000
Phase II Studies of the Glycine Antagonist GV150526 in Acute Stroke 2000
Bilateral movement enhances cortical activity associated with the paretic hand in acute stroke: A functional magnetic resonance imaging (FMRI) study 2000
The risk of intracranial hemorrhage in patients after cerebral ischemia without and with atrial fibrillation on oral anticoagulation (SPIRIT vs EAFT) 1999
Effects of isovolemic hemodilution on T2*-weighted magnetic resonance images of rat brain. 1998
Etiology of Stroke 1997
Accurate quantitation of regional brain water content in vivo 1997
Quantitative regional cerebral water measurement in a stroke model with MRI 1996
PROSTHETIC VALVE ENDOCARDITIS (PVE) - ANTIBIOTICS, ANTICOAGULATION AND STROKE 1988
Validation of Clinical-Radiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-related inflammation
Cardiorespiratory Fitness Benefits of High-Intensity Interval Training After Stroke: A Randomized Controlled Trial. 55:2202-2211. 2024
Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry. 55:2103-2112. 2024
Stroke Genetics, Genomics, and Precision Medicine. 55:2163-2168. 2024
Combining Early Ischemic Change and Collateral Extent for Functional Outcomes After Endovascular Therapy: An Analysis From AcT Trial. 55:1758-1766. 2024
Hemorrhagic Transformation in Noncardioembolic Acute Ischemic Stroke: MRI Analysis From PACIFIC-STROKE. 55:1477-1488. 2024
Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial. 55:524-531. 2024
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes. 55:392-402. 2024
Sex-Based Analysis of Workflow and Outcomes in Acute Ischemic Stroke Patients Treated With Alteplase Versus Tenecteplase. 55:288-295. 2024
Previous Ischemic Stroke Significantly Alters Stroke Risk in Newly Diagnosed Cancer Patients. 54:3064-3073. 2023
Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial. 54:2766-2775. 2023
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis. 54:2724-2736. 2023
Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation. 54:2542-2551. 2023
Is There Still a Role for Dual Antiplatelet Therapy in the Secondary Prevention of Lacunar Stroke?. 54:2251-2253. 2023
Infarcts in a New Territory: Insights From the ESCAPE-NA1 Trial. 54:1477-1483. 2023
Prospective Validation of Computed Tomography to Identify Patients at High Risk for Stroke After Transient Ischemic Attack or Minor Stroke. 54:1030-1036. 2023
Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial. 54:715-721. 2023
Abstract WP71: Endovascular Thrombectomy With Or Without Bridging Thrombolysis In Patients With Acute Ischemic Stroke: A Cost-utility Analysis. 54:awp71-awp71. 2023
Timing of Antiplatelet Resumption After Intracerebral Hemorrhage: A Sophie’s Choice. 54:546-548. 2023
Using Noncontrast Computed Tomography to Improve Prediction of Intracerebral Hemorrhage Expansion. 54:567-574. 2023
Anti-Epileptic Drug Target Perturbation and Intracranial Aneurysm Risk: Mendelian Randomization and Colocalization Study. 54:208-216. 2023
Clinical, Neuroimaging, and Genetic Markers in Cerebral Amyloid Angiopathy-Related Inflammation: A Systematic Review and Meta-Analysis. 54:178-188. 2023
Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art. 54:270-278. 2023
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. 53:e282-e361. 2022
Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage. 53:2161-2170. 2022
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis. 53:1944-1953. 2022
Abstract WMP99: Proteomics Study Of Stroke In Young Adults. 53:awmp99-awmp99. 2022
Frequency and Patterns of Brain Infarction in Patients With Embolic Stroke of Undetermined Source: NAVIGATE ESUS Trial. 53:45-52. 2022
Changes in Stroke Hospital Care During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. 52:3651-3660. 2021
Prevalence, Characteristics, and Outcomes of Undetermined Intracerebral Hemorrhage: A Systematic Review and Meta-Analysis. 52:3602-3612. 2021
Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure. 52:3151-3162. 2021
Cilostazol for Secondary Stroke Prevention. 52:e635-e645. 2021
Tandem Occlusions. 52:3106-3108. 2021
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial. 52:2494-2501. 2021
Causal Effect of MMP-1 (Matrix Metalloproteinase-1), MMP-8, and MMP-12 Levels on Ischemic Stroke. 52:e316-e320. 2021
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy. 52:2096-2105. 2021
Intracerebral Hemorrhage Incidence, Mortality, and Association With Oral Anticoagulation Use. 52:1673-1681. 2021
Combatting Secondary Injury From Intracerebral Hemorrhage With Supplemental Antioxidant Therapy. 52:1182-1184. 2021
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention. 52:1450-1454. 2021
The Impact of SARS‐CoV‐2 on Stroke Epidemiology and Care: A Meta‐Analysis. 89:380-388. 2021
Imaging Predictors of Neurologic Outcome After Pediatric Arterial Ischemic Stroke. 52:152-161. 2021
Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions. 52:308-312. 2021
Beyond the Brain. 51:3007-3017. 2020
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline. 51:2901-2909. 2020
How to Be Savvy About Gender Disparities in Academic Stroke Medicine. 51:e261-e265. 2020
Genome-Wide Association Study Meta-Analysis of Stroke in 22 000 Individuals of African Descent Identifies Novel Associations With Stroke. 51:2454-2463. 2020
High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source. 51:2386-2394. 2020
Frequency and Predictors of Major Bleeding in Patients With Embolic Strokes of Undetermined Source. 51:2139-2147. 2020
Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke. 51:1190-1198. 2020
Global Assessment of Mendelian Stroke Genetic Prevalence in 101 635 Individuals From 7 Ethnic Groups. 51:1290-1293. 2020
Recommendations for Clinical Trials in ICH. 51:1333-1338. 2020
Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging–Detected Vascular Brain Injury. 51:1158-1165. 2020
Atrial Cardiopathy and Nonstenosing Large Artery Plaque in Patients With Embolic Stroke of Undetermined Source. 51:938-943. 2020
Abstract WP487: Retinal Vessel Tortuosity Correlates With White Matter Hyperintensities and Cerebral Microbleeds in Subjects With Cognitive Decline. 51. 2020
Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease. 50:3347-3354. 2019
Education in Stroke Medicine. 50:e421-e423. 2019
Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials. 50:2187-2196. 2019
Stroke and Cerebrovascular Disease in Pregnancy. 50:13-20. 2019
Pharmacogenetics of Stroke. 49:2541-2548. 2018
Experience, the Name We Give Our Mistakes. 49:e273-e275. 2018
Basic and Translational Research in Intracerebral Hemorrhage. 49:1308-1314. 2018
Unmet Needs and Challenges in Clinical Research of Intracerebral Hemorrhage. 49:1299-1307. 2018
Stroke in Women. 49:515-517. 2018
Abstract 15: Mortality After Pediatric Arterial Ischemic Stroke: Results From the International Paediatric Stroke Study. 49. 2018
Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?. 48:3408-3412. 2017
Identifying the Right Mentor. 48:e248-e251. 2017
Mendelian Genes and Risk of Intracerebral Hemorrhage and Small-Vessel Ischemic Stroke in Sporadic Cases. 48:2263-2265. 2017
Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis. 48:2084-2090. 2017
Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke. 48:1760-1765. 2017
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents. 48:1432-1437. 2017
Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation. 48:1306-1315. 2017
Embolic Stroke of Undetermined Source. 48:867-872. 2017
Cerebral Microbleeds as Predictors of Mortality. 48:781-783. 2017
Impact of Expanding the Prehospital Stroke Bypass Time Window in a Large Geographic Region. 48:624-630. 2017
Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting With Minor Cerebrovascular Events. 47:2236-2241. 2016
Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke. 47:2197-2202. 2016
Inflammatory Biomarkers in Childhood Arterial Ischemic Stroke. 47:2221-2228. 2016
Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke. 47:2380-2385. 2016
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events. 47:2075-2082. 2016
Arterial Tortuosity: An Imaging Biomarker of Childhood Stroke Pathogenesis?. 47:1265-1270. 2016
Peripheral Blood MCEMP1 Gene Expression as a Biomarker for Stroke Prognosis. 47:652-658. 2016
Predicting Intracerebral Hemorrhage Growth With the Spot Sign. 47:695-700. 2016
Validating a Pragmatic Approach to Cognitive Screening in Stroke Prevention Clinics Using the Montreal Cognitive Assessment. 47:807-813. 2016
Abstract 212: Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers. 47. 2016
Correction. 47:e20. 2016
Risk of Recurrent Arterial Ischemic Stroke in Childhood. 47:53-59. 2016
Management of Central Poststroke Pain. 46:2853-2860. 2015
Rapid Assessment and Treatment of Transient Ischemic Attacks and Minor Stroke in Canadian Emergency Departments. 46:2987-2990. 2015
Serum Leptin Levels and the Risk of Stroke. 46:2881-2885. 2015
Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke. 46:936-941. 2015
Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke. 46:1014-1023. 2015
Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation. 46:1120-1122. 2015
Impact of Language Barriers on Stroke Care and Outcomes. 46:813-818. 2015
Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure. 46:667-672. 2015
Thrombolysis in Pediatric Stroke Study. 46:880-885. 2015
Abstract W MP119: Sensitivity and Reliability of MRI SWI Compared With GRE Sequences for Detecting Microbleeds in a Community Population. 46. 2015
Abstract W P156: Arterial Stiffness in Older Adults With and Without Stroke. 46. 2015
Computed Tomography Identifies Patients at High Risk for Stroke After Transient Ischemic Attack/Nondisabling Stroke. 46:114-119. 2015
Intensity and Quality of Warfarin Anticoagulation in Chinese Patients. 46:5-6. 2015
Recommendations From the International Stroke Genetics Consortium, Part 2. 46:285-290. 2015
Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation. 45:3637-3642. 2014
Arteriopathy Diagnosis in Childhood Arterial Ischemic Stroke. 45:3597-3605. 2014
Predictors of Mortality in Patients With Lacunar Stroke in the Secondary Prevention of Small Subcortical Strokes Trial. 45:2989-2994. 2014
Larger A1/M1 Diameter Ratio Predicts Embolic Anterior Cerebral Artery Territorial Stroke. 45:2798-2800. 2014
Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin. 45:2372-2378. 2014
Physical Activity and Exercise Recommendations for Stroke Survivors. 45:2532-2553. 2014
Effect of Genetic Variants Associated With Plasma Homocysteine Levels on Stroke Risk. 45:1920-1924. 2014
Emergence of the Primary Pediatric Stroke Center. 45:2018-2023. 2014
Incidental Magnetic Resonance Diffusion-Weighted Imaging–Positive Lesions Are Rare in Neurologically Asymptomatic Community-Dwelling Adults. 45:2115-2117. 2014
Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation. 45:2127-2130. 2014
Vitamin K Antagonists and Risk of Subdural Hematoma. 45:1672-1678. 2014
What Makes Family Caregivers Happy During the First 2 Years Post Stroke?. 45:1084-1089. 2014
A Prospective Cohort Study of Patients With Transient Ischemic Attack to Identify High-Risk Clinical Characteristics. 45:92-100. 2014
Evolution of Computed Tomography Angiography Spot Sign Is Consistent With a Site of Active Hemorrhage in Acute Intracerebral Hemorrhage. 45:277-280. 2014
Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease. 44:2688-2693. 2013
CT Perfusion in Acute Stroke: Added Value or Waste of Time?. 44:e115. 2013
Satisfaction With Palliative Care After Stroke. 44:2617-2619. 2013
Effect of B Vitamins and Lowering Homocysteine on Cognitive Impairment in Patients With Previous Stroke or Transient Ischemic Attack. 44:2232-2239. 2013
Dabigatran Versus Warfarin. 44:1891-1896. 2013
Thrombolysis Despite Recent Stroke. 44:1736-1738. 2013
Chronic Pain Syndromes After Ischemic Stroke. 44:1238-1243. 2013
Abstract TMP9: The Neurovision Pilot Study: Non-cardiac Surgery Carries A Significant Risk Of Acute Covert Stroke. 44. 2013
Abstract WP191: Framingham Stroke Risk Score and Stroke Mortality Among Canadian Adults. 44. 2013
Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study. 44:249-251. 2013
B Vitamins and Magnetic Resonance Imaging–Detected Ischemic Brain Lesions in Patients With Recent Transient Ischemic Attack or Stroke. 43:3266-3270. 2012
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin. 43:3291-3297. 2012
Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?. 43:2048-2054. 2012
Association of Statins and Statin Discontinuation With Poor Outcome and Survival After Intracerebral Hemorrhage. 43:1518-1523. 2012
Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran. 43:1511-1517. 2012
Treatment With B Vitamins and Incidence of Cancer in Patients With Previous Stroke or Transient Ischemic Attack. 43:1572-1577. 2012
Letter by Van de Werf et al Regarding Article, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians”. 43:e46-e47. 2012
The Feasibility of Cardiopulmonary Exercise Testing for Prescribing Exercise to People After Stroke. 43:1075-1081. 2012
Resumption of Oral Anticoagulation After Warfarin-Associated Intracerebral Hemorrhage. 42:3663-3664. 2011
The iScore Predicts Poor Functional Outcomes Early After Hospitalization for an Acute Ischemic Stroke. 42:3421-3428. 2011
Stroke Survivor Depressive Symptoms Are Associated With Family Caregiver Depression During the First 2 Years Poststroke. 42:302-306. 2011
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage. 41:2860-2866. 2010
Stratified, Urgent Care for Transient Ischemic Attack Results in Low Stroke Rates. 41:2601-2605. 2010
The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin. 41:2398-2399. 2010
National Survey of Canadian Neurologists’ Current Practice for Transient Ischemic Attack and the Need for a Clinical Decision Rule. 41:987-991. 2010
Advances in Genomic Analysis of Stroke. 41:825-832. 2010
Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke. 41:732-738. 2010
Strength Training Improves Upper-Limb Function in Individuals With Stroke. 41:136-140. 2010
A Citywide Prehospital Protocol Increases Access to Stroke Thrombolysis in Toronto. 40:3841-3844. 2009
Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke. 40:3541-3546. 2009
Multi-Ethnic Genetic Association Study of Carotid Intima-Media Thickness Using a Targeted Cardiovascular SNP Microarray. 40:3173-3179. 2009
Response to Letter by Obeid and Herrmann. 40:E517-E517. 2009
A Self-Administered Graded Repetitive Arm Supplementary Program (GRASP) Improves Arm Function During Inpatient Stroke Rehabilitation. 40:2123-2128. 2009
Ethnicity Does Not Affect the Homocysteine-Lowering Effect of B-Vitamin Therapy in Singaporean Stroke Patients. 40:2209-2211. 2009
Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability. 40:1365-1372. 2009
The Toronto Bedside Swallowing Screening Test (TOR-BSST). 40:555-561. 2009
Correction. 39:E147-E147. 2008
Escalating Levels of Access to In-Hospital Care and Stroke Mortality. 39:2522-2530. 2008
Practical Model-Based Dose Finding in Early-Phase Clinical Trials. 39:2627-2636. 2008
Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke. 39:2318-2324. 2008
Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation. 39:1901-1910. 2008
Response to Letter by Haft. 39:E92-E92. 2008
Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke. 39:1638-1646. 2008
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk. 39:1482-1486. 2008
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks. 39:1399-1400. 2008
Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke. 38:2935-2940. 2007
The Economics of Thrombolysis. 38:1732-1733. 2007
CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage. 38:1257-1262. 2007
Cerebral Blood Flow Threshold of Ischemic Penumbra and Infarct Core in Acute Ischemic Stroke: A Systematic Review. 37:2201-2201. 2006
American Stroke Association Guideline Policies. 37:1965-1965. 2006
Identification of Penumbra and Infarct in Acute Ischemic Stroke Using Computed Tomography Perfusion–Derived Blood Flow and Blood Volume Measurements. 37:1771-1777. 2006
Primary Prevention of Ischemic Stroke. 37:1583-1633. 2006
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.. 37:1583-1633. 2006
Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?. 37:452-455. 2006
Methylenetetrahydrofolate Reductase Polymorphisms and Homocysteine-Lowering Effect of Vitamin Therapy in Singaporean Stroke Patients. 37:456-460. 2006
Physiotherapy Coupled With Dextroamphetamine for Rehabilitation After Hemiparetic Stroke. 37:179-185. 2006
Urgent Clinical Challenges in Children With Ischemic Stroke. 37:116-122. 2006
A New Visual Rating Scale to Assess Strategic White Matter Hyperintensities Within Cholinergic Pathways in Dementia. 36:2126-2131. 2005
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack. 36:2164-2169. 2005
3D Ultrasound Measurement of Change in Carotid Plaque Volume. 36:1904-1909. 2005
Protein Z Levels, Protein Z G79A Polymorphism, and Prothrombotic Conditions. 36:1821-1822. 2005
Protein Z Gene Polymorphisms, Protein Z Concentrations, and Ischemic Stroke. 36:1123-1127. 2005
Homocysteine-Lowering Treatment With Folic Acid, Cobalamin, and Pyridoxine Does Not Reduce Blood Markers of Inflammation, Endothelial Dysfunction, or Hypercoagulability in Patients With Previous Transient Ischemic Attack or Stroke. 36:144-146. 2005
Folic Acid–Based Multivitamin Therapy to Prevent Stroke. 35:1995-1998. 2004
Agreement Between Patient and Proxy Assessments of Health-Related Quality of Life After Stroke Using the EQ-5D and Health Utilities Index. 35:607-612. 2004
Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?. 35:389-391. 2004
Cyclooxygenase-2 Inhibitors. 34:2736-2740. 2003
Protein Z in Ischemic Stroke and its Etiologic Subtypes. 34:2415-2419. 2003
Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiological Subtypes. 34:2132-2137. 2003
Editorial Comment—Routine Thrombophilia Testing in Stroke Patients Is Unjustified. 34:1826-1827. 2003
Somatosensory Gating and Recovery From Stroke Involving the Thalamus. 33:2642-2651. 2002
Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question. 33:1947-1948. 2002
Selective Vulnerability of the Lumbosacral Spinal Cord After Cardiac Arrest and Hypotension. 33:116-121. 2002
Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients. 32:2426-2432. 2001
Inherited Thrombophilia in Ischemic Stroke and Its Pathogenic Subtypes. 32:1793-1799. 2001
Association Between High Homocyst(e)ine and Ischemic Stroke due to Large- and Small-Artery Disease but Not Other Etiologic Subtypes of Ischemic Stroke. 31:1069-1075. 2000
Abciximab in Acute Ischemic Stroke. 31:601-609. 2000
The Stroke Prognosis Instrument II (SPI-II). 31:456-462. 2000
The North American Symptomatic Carotid Endarterectomy Trial. 30:1751-1758. 1999
Diminished Serotonin-Mediated Prolactin Responses in Nondepressed Stroke Patients Compared With Healthy Normal Subjects. 29:1293-1298. 1998
Use of the Health Utilities Index With Stroke Patients and Their Caregivers. 28:1888-1894. 1997
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Etiology of stroke.. 28:1501-1506. 1997
Accuracy and Prognostic Consequences of Ultrasonography in Identifying Severe Carotid Artery Stenosis. 26:1747-1752. 1995
Spontaneous Thrombosis of an Unruptured Anterior Communicating Artery Aneurysm. 26:1945-1949. 1995
Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial.. 25:1552-1558. 1994
The relevance of detecting carotid artery calcification on plain radiograph.. 24:1330-1334. 1993
Electric injury with cerebral venous thrombosis. Case report and review of the literature.. 24:903-905. 1993
Measuring physical impairment and disability with the Chedoke-McMaster Stroke Assessment.. 24:58-63. 1993
Design and baseline results of the monosialoganglioside early stroke trial. The EST Study Group.. 23:519-526. 1992
Denervation in hemiplegic muscles.. 21:1700-1704. 1990
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.. 19:1203-1210. 1988
Proposed method for analyzing carotid endarterectomy results.. 19:1180-1181. 1988
Carotid endarterectomy: three critical evaluations. North American Symptomatic Carotid Endarterectomy Study Group.. 18:987-989. 1987
Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies.. 18:1107-1112. 1987
Calcific cerebral emboli and aortic stenosis: detection of computed tomography.. 17:619-621. 1986
Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.. 17:111-116. 1986
Atrial fibrillation and the diagnosis of cardioembolic stroke.. 16:1043-1044. 1985
A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke.. 16:416-424. 1985
Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.. 16:1-4. 1985
THE RELATIONSHIP BETWEEN DOSE OF ASPIRIN, SIDE-EFFECTS AND ANTITHROMBOTIC EFFECTIVENESS. 16:1-4. 1985
Sample size for randomized trials in stroke prevention. How many patients do we need?. 15:968-971. 1984
MITRAL-VALVE PROLAPSE AND RISK OF STROKE - REPLY. 14:1011-1012. 1983
Mechanisms of perioperative cerebral infarction.. 13:766-773. 1982
Practical considerations in antifibrinolytic therapy.. 13:722-723. 1982
The international EC/IC bypass study.. 13:247-248. 1982

Stroke Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)